“America’s Futurist” reveals to his subscribers details of a tiny American biotech uncovering cures for malaria, cancer, and Parkinson’s...

“The Naked Antibody That Gets Cancer Cells to Kill Themselves!”

Report hints at why investing in this biotech company could deliver massive returns...

Get Your Free Report:

As a bonus we will include a link where you can become a Private Reserve member at a fraction of the price the public will pay. As well as George Gilder's free weekly e-letter, Gilder's Guideposts, and other breaking financial news and offers. (Privacy Policy)

George Gilder says:
"This biotech has some amazing therapies in the pipeline, including an innovative single injection cure for malaria that could be more effective than any current remedy, and an anti-colon cancer therapy using the same innovative therapeutic approach… This is big stuff.”

Steve Forbes says:
"Few men and women in modern times have been so consistently farsighted in fathoming the future of high technology as George Gilder has been."

Rush Limbaugh says:
"It would behoove you to study everything you can get your hands on by George Gilder, a true American genius."

George Gilder recently alerted his top subscribers to an American biotech company with a pipeline of discoveries, inventions, and therapeutic applications that George called, “Big stuff.”

In this potentially very lucrative report, George shared how the company is making huge progress for malaria, colon cancer… even Parkinson’s disease. It is making advancements and discoveries in crucial treatments including:

• A Discovery: a tiny antibody which blocks a protein that allows cancer cells to grow, and which malaria parasites need to infect people.
• Cancer Therapies: Smart therapies that enables cancer cells to actually kill themselves!
• Gene Therapies: New techniques for regenerating neurons, heart cells, and eye cells. This includes a potential treatment for Parkinson’s disease that transforms brain astrocytes into neurons (astrocytes make up the majority of cells in your central nervous system).

If just one of their discoveries continued to show promise, it would become a huge advancement in medicine. And, at that point, early stage investors could stand to reap the rewards of their investing foresight.

The promise these types of biotech innovations and discoveries bring is a massive, potentially disruptive force in medicine as we know it.

George’s report on this company is in-depth and brings his members details of the company, its discoveries, advancements, and potential for cures. But it also outlines how smart investors can currently invest in the company (hint: it’s not in the usual way you might think).

And getting in as an early stage investor in companies like the one George just wrote about could mean handsome returns in future.

(Naturally, anyone considering investing in anything should satisfy themselves as to not only what the investment is and the discoveries and potential George has written about, but their own investing goals, timelines, and risk-tolerance.)

George recently sent this report to his top subscribers. “Top” because each of them pays up to $4,995 a year to be a member of his Private Reserve service. As a member of Private Reserve, members finally get access to the kind of private placement, Pre-IPO, opportunities that have previously been reserved only for insiders.

I’m talking about early-in investments with the potential to 10X, 50X, 100X or more investors’ money.

At $4,995 a year, George’s members’ report on this American biotech company is worth over $400. But currently at this special web page, it’s yours for $0. $0… why? Simple: we want to provide a real example of a Private Reserve members’ report because we believe that you will want to receive many more of this type of reports and insights from George. Sending you one of his most recent reports allows you to see what his members receive.

There’s no obligation and nobody will spam you. And, along with the report (the same one his members received), we will include a special link to receive Private Reserve for the next year at a fraction of the published price at George’s website!

Get Your Free Report:

As a bonus we will include a link where you can become a Private Reserve member at a fraction of the price the public will pay. As well as George Gilder's free weekly e-letter, Gilder's Guideposts, and other breaking financial news and offers. (Privacy Policy)

Intrigued? Download Gilder’s valuable biotech report at this page while it’s still available.